1. Home
  2. Author
  3. Takeda-Watanabe A

Takeda-Watanabe A

References (2)

Title : Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner - Kitada_2017_BMJ.Open.Diabetes.Res.Care_5_e000391
Author(s) : Kitada M , Tsuda SI , Konishi K , Takeda-Watanabe A , Fujii M , Kanasaki K , Nishizawa M , Nakagawa A , Koya D
Ref : BMJ Open Diabetes Res Care , 5 :e000391 , 2017
Abstract :
PubMedSearch : Kitada_2017_BMJ.Open.Diabetes.Res.Care_5_e000391
PubMedID: 28761658

Title : Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner - Kitada_2017_BMJ.Open.Diabetes.Res.Care_5_e000391
Author(s) : Kitada M , Tsuda SI , Konishi K , Takeda-Watanabe A , Fujii M , Kanasaki K , Nishizawa M , Nakagawa A , Koya D
Ref : BMJ Open Diabetes Res Care , 5 :e000391 , 2017
Abstract :
PubMedSearch : Kitada_2017_BMJ.Open.Diabetes.Res.Care_5_e000391
PubMedID: 28761658